Abstract Background Community prescribing of medication to treat psychiatric illness in children is increasing. However, details about medication prescribed at discharge from psychiatric inpatient services for children are scarce. Objectives Characterise the nature of psychotropic medication prescribed on discharge from a children's psychiatric ward over a 15-year period. Method Retrospective analysis of discharge summary letters of all discharges occurring between Jan 1997 to Dec 2012. Results 234 children (152 males and 82 females) were discharged with 117 (50 %) prescribed psychotropic medication at discharge. 133 medicines were prescribed (stimulants n = 49, antipsychotics n = 31, antidepressants n = 22, mood stabilisers n = 1, other ADHD medication n = 11, melatonin n = 10, benzodiazepines n = 7, other n = 2). Risperidone was the most popular antipsychotic at a mean daily dose of 1 mg (range 0.25-4 mg). Fifty per cent were given an unlicensed medicine or a licensed drug was used in an unlicensed manner, of which risperidone was the most common (n = 14). Sleep disturbance and tics were most often treated using unlicensed/off label medication (n = 10). Conclusion Psychotropic medication is routinely used in inpatient children's services, with the majority of use confined to stimulants and atypical antipsychotics. Much of the antipsychotic use is for unlicensed indications or at unlicensed doses.
Impact of findings
• In the UK, stimulant medication and atypical antipsychotics are commonly prescribed upon discharge from children's psychiatric in-patient services.
• Upon discharge from children's psychiatric inpatient services in the UK, much of the prescribing consists of unlicensed doses or unlicensed indications the majority of which occurs with risperidone.
• Sleep disturbance and tics are largely treated using unlicensed/off label medication.
Background
Psychotropic medication is increasingly used in children to treat psychiatric symptoms or illnesses [1] and behaviours associated with autistic spectrum disorders [2] . Child and adolescent psychiatrists report that stimulants or antipsychotics, namely the atypical antipsychotics, are the medicines they use most frequently in this population [3] . However, the majority of prevalence studies tend to be based upon community or outpatient populations. Information about psychotropic medication use in children's in-patient psychiatric services is largely non-existent. In the UK, there are eight NHS inpatient psychiatric units for children aged 12 years and younger. The units tend to be small (6-10 beds) with an average length of stay of 116 days [4] . Despite the controversial nature of admitting children with mental health issues to in-patient units, they can have a positive impact compared to outpatient interventions, particularly in life threatening situations e.g. severe depression, eating disorders [4] . Much of the pharmacological treatment of childhood psychiatric conditions is based upon knowledge and experience of the medication in adult populations. Prescribing governance for psychotropic medication use in children is often limited and much of the medication is used in an unlicensed or 'off label' manner [5] . This includes using licensed medicines for unlicensed indications e.g. clonidine for treatment of Attention Deficit Hyperactivity Disorder [ADHD] or using unlicensed doses. By characterising the nature of psychotropic medication used in one children's psychiatric unit, this paper intends to inform prescribing practice within this highly specialised area.
Objective
To characterise the nature of psychotropic medication prescribed on discharge from a children's psychiatric unit over a 15 year period.
Ethical approval
Ethical approval was not required as the study involved analysis of routinely collected anonymous prescribing data and was therefore considered as service evaluation/service development as per the Governance Arrangements for UK Research Ethics Committees.
Method
A retrospective analysis of discharge summary letters for all children discharged from a psychiatric unit between January 1997 and December 2012. Anonymous demographic and discharge medication details were extracted. Only medication prescribed for treatment of a psychiatric condition, including emotional or behavioural symptoms and treatment of neuro-developmental disorders including tics was included. Medication for seizure control was excluded. Nonpsychotropic medicines were included if they were used for psychiatric reasons. Other details' concerning dosages and indication, where available was also extracted.
Results

Patient population
234 children [152 males (65 %) and 82 females] were admitted over the study period with a mean of 15 admissions per year. The mean age on admission was 9 years, 7 months (range 4-14 years). 117 patients (50 %) were prescribed psychotropic medication on discharge, including 24 (n = 19 males) who were discharged on more than one psychotropic medicine. Overall, 133 medicines were prescribed at discharge. These consisted of; stimulants (immediate release n = 35, sustained release n = 14), antipsychotics (atypical n = 23, typical n = 8), antidepressants (SSRIs n = 15, other n = 7), other medication used for ADHD (n = 11), melatonin (n = 10), benzodiazepines (n = 7), sodium valproate (n = 1) and other medications (hyoscine n = 1 and alimemazine n = 1).
Antipsychotics 31 patients (26 %) were discharged on an antipsychotic. The majority were male (n = 21, 68 %) with a mean age of 11 years. Risperidone was most frequently prescribed (n = 14) at a mean daily dose of 1 mg (range 0.25-4 mg, based upon 14 patients). As the number of children discharged on an antipsychotic was relatively small every year; further analysis to find trends/rates in prescribing was not possible.
Stimulants and other ADHD medication
55 patients (47 %) were discharged on a stimulant or another medication used for treating the symptoms of ADHD. 96 % (n = 53) were male with a mean age of 10 years. Some individuals were prescribed combinations of immediate and sustained release methylphenidate (MPH) (n = 42); methylphenidate or dexamfetamine augmented with either atomoxetine (n = 6) or clonidine (n = 6). Further analysis to determine trends in the rate of prescribing was not performed.
Unlicensed use
59 patients (50 % of all patients discharged on medication, 25 % of the total sample) were given an unlicensed medicine or a licensed drug was used in an unlicensed manner (See Table 1 ). Risperidone was the most common drug to be used in this manner (n = 14). Sleep disturbance and tics were the most common diagnosis to be treated using unlicensed/off label medication (n = 10).
Discussion
Fifty per cent of children discharged from the unit were prescribed a psychotropic medication, of which stimulants were the most popular. This does not mean that all discharges had a definitive diagnosis of ADHD-but rather elements of inattention, hyperactivity or impulsivity were apparent and treated as such. Movement and autistic spectrum disorders were also common amongst this cohort and widely recognised as occurring alongside ADHD. For example, 60-70 % of children with ADHD have Tourette's syndrome [6] . This often results in 'ADHD medication' being used in an unlicensed manner e.g atomoxetine for attentional/hyperactivity symptoms in patients on the autistic spectrum or with Tourette's syndrome. Similarly, methylphenidate for ADHD may be used alongside behavioural co-morbidites and at higher than licensed doses e.g. 72 mg daily. Clonidine, licensed for hypertension is also effective in ADHD with the unlicensed use of clonidine specifically referred to in the NICE ADHD guidelines [7] . Melatonin is a recognised treatment for sleep disorders in children and widely prescribed at discharge. However, there are no licensed preparations in the UK for children. Generally, prescribers use the Circadian Ò brand but in an off license manner or the Bio-Melatonin brand which has an EU but not a UK license. The majority of unlicensed medication use on this unit occurs with the antipsychotics, particularly risperidone. Most prescribed doses for risperidone were within the licensed dosage range for treatment of persistent/severe aggression in children with conduct disorder. However, its use is unlikely to be restricted to a 'conduct disordered' population. Regardless of the complexities of specific diagnosis and associated symptoms, risperidone is effective against aggression and irritability, which explains its use amongst children with ASD, anxiety and ADHD, all of which exhibit elements of aggression and irritability, sometimes called 'challenging behaviour'. This is similar to the situation found in the elderly where antipsychotics have been used to address 'behaviours associated with dementia'. The atypical antipsychotics were initially perceived to have a better side effect profile than the older typical antipsychotics. However, complications arising from weight gain, metabolic syndrome and hyper-prolactinaemia caused by the atypicals have curbed initial enthusiasm [8] . In adults, regular monitoring of physical parameters (LFTs, U&Es, fasting plasma glucose, HbA 1C etc) is recommended and should occur at the start of treatment and at subsequent dosage increases [9] . In children, particularly those with mental health issues, such monitoring poses its own set of It is unfortunate that patient turnover and hence discharges from the unit were relatively modest. This is partly indicative of mental health services in general, where inpatient stays tend to be for a longer period. Additionally, given the added complexity of co-ordinating care with other (children's) services upon discharge, inpatient stays for children can become rather protracted. This partly explains the low average number of discharges (15 per year) seen in this study. The small number of children discharged on antipsychotics each year, made it difficult to analyse the data in a longitudinal manner. However, it is clear that a range of antipsychotics, including the older typical drugs have been in use over the past 15 years. The arrival of the atypical antipsychoticsis thought to be a contributing factor to the increased use seen in the community. It is unknown whether this has been a factor in unit prescribing.
Unlike adult services where psychotropic medication is prescribed to many patients at discharge, only half of those discharged from this unit were prescribed psychotropic medication. One reason could be that since the majority of cases had elements of anxiety associated with them, and psychological treatment is the preferred option for these [10] , the low number indicates that psychological therapies are being 'prescribed' instead of medication. This would need to be further investigated. Alternatively, perhaps clinicians, wary of the limited knowledge concerning long term use of psychotropic medication on the developing brain, are choosing to time limit the duration that such medication is being taken by their patients.
This study describes the nature of psychotropic medication prescribed on discharge from a specialist inpatient unit and cannot be generalised to patterns of prescribing seen in community paediatric populations receiving psychiatric care.
Conclusion
Stimulants and atypical antipsychotics are the most commonly prescribed drugs on discharge from a children's psychiatric ward. Much of the antipsychotic use is for unlicensed indications or at unlicensed doses.
